GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Progen Co Ltd (XKRX:296160) » Definitions » Change In Inventory

Progen Co (XKRX:296160) Change In Inventory : ₩0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Progen Co Change In Inventory?

Progen Co's change in inventory for the quarter that ended in Dec. 2024 was ₩0.0 Mil. It means Progen Co's inventory stayed the same from Dec. 2023 to Dec. 2024 .

Progen Co's change in inventory for the fiscal year that ended in Dec. 2024 was ₩0.0 Mil. It means Progen Co's inventory stayed the same from Dec. 2023 to Dec. 2024 .

Progen Co's Total Inventories for the quarter that ended in Dec. 2024 was ₩0.0 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Progen Co's Days Inventory for the quarter that ended in Dec. 2024 was 0.00.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Progen Co's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.00.


Progen Co Change In Inventory Historical Data

The historical data trend for Progen Co's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Progen Co Change In Inventory Chart

Progen Co Annual Data
Trend Dec23 Dec24
Change In Inventory
- -

Progen Co Semi-Annual Data
Dec23 Dec24
Change In Inventory - -

Progen Co Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2024 was ₩0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Progen Co  (XKRX:296160) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Progen Co's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=0/37.467*365 / 2
=0.00

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Progen Co's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Progen Co's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Progen Co Change In Inventory Related Terms

Thank you for viewing the detailed overview of Progen Co's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Progen Co Business Description

Traded in Other Exchanges
N/A
Address
172 Magokjungang-ro, 7th Floor, Bio Innovation Park, Gangseo-gu, Seoul, KOR
Progen Co Ltd is an R&D focused biopharmaceutical development venture. It is engaged in developing metabolic disease treatments, immune disease treatments, and immune anti cancer drugs using its immunology based drug development know how, and is focusing on developing inventive drugs through domestic and international open innovation.

Progen Co Headlines

No Headlines